Burns J W & Co. Inc. NY Has $7.26 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Burns J W & Co. Inc. NY trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the fourth quarter, Holdings Channel reports. The firm owned 14,343 shares of the healthcare conglomerate’s stock after selling 246 shares during the quarter. UnitedHealth Group comprises approximately 0.9% of Burns J W & Co. Inc. NY’s investment portfolio, making the stock its 29th biggest position. Burns J W & Co. Inc. NY’s holdings in UnitedHealth Group were worth $7,256,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. M&T Bank Corp lifted its stake in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC grew its holdings in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the period. Benjamin Edwards Inc. raised its stake in UnitedHealth Group by 1,275.3% in the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP bought a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $21,165,000. Finally, Discipline Wealth Solutions LLC acquired a new stake in UnitedHealth Group during the 3rd quarter valued at $558,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $541.28 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market capitalization of $498.13 billion, a P/E ratio of 35.26, a PEG ratio of 1.53 and a beta of 0.62. The company has a fifty day moving average price of $554.92 and a 200-day moving average price of $562.88.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the firm posted $6.56 earnings per share. The business’s quarterly revenue was up 9.2% on a year-over-year basis. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

A number of research analysts recently commented on UNH shares. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Cantor Fitzgerald boosted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Bank of America decreased their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Two investment analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.